Approaches to modernize the combination drug development paradigm

por Day, Daphne, Siu, Lillian L.
Publicado 2016

Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review

por Tan, Sean, Day, Daphne, Nicholls, Stephen J., Segelov, Eva
Publicado 2022

Synchronous p16(+) nasopharyngeal and oropharyngeal squamous cell carcinoma: a case report and review

por Ali, Muhammad, Kua, Hock, Giddings, Charles, Day, Daphne, McDowell, Lachlan
Publicado 2021

Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six‐year experience in a large institution

por Menon, Siddharth, Davies, Amy, Frentzas, Sophia, Hawkins, Cheryl‐Ann, Segelov, Eva, Day, Daphne, Markman, Ben
Publicado 2021

Operational Challenges of an Asia-Pacific Academic Oncology Clinical Trial

por Day, Daphne, Toh, Han Chong, Ali, Raghib, Foo, Estelle Mei Jye, Simes, John, Chia, John Whay Kuang, Segelov, Eva
Publicado 2023

Enhanced toxicity with CDK 4/6 inhibitors and palliative radiotherapy: Non-consecutive case series and review of the literature

por David, Steven, Ho, Gwo, Day, Daphne, Harris, Marion, Tan, Jennifer, Goel, Shom, Hanna, Gerard G., Srivastava, Ranjana, Kruss, Gill, McDowell, Lachlan, White, Michelle
Publicado 2020

Factors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Usin...

por Choi, Tammie, Chan, Bryan, Grech, Lisa, Kwok, Alastair, Webber, Kate, Wong, Jennifer, Nguyen, Mike, Bain, Nathan, Day, Daphne, McCartney, Amelia, Hamer, Ruby, Segelov, Eva
Publicado 2023

Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS‐001 clinical trial

por Hernando‐Calvo, Alberto, Malone, Eoghan, Day, Daphne, Prawira, Amy, Weinreb, Ilan, Yang, S. Y. Cindy, Wong, Horace, Rodriguez, Angela, Jennings, Sarah, Eliason, Anneli, Wang, Lisa, Spreafico, Anna, Siu, Lillian L., Hansen, Aaron R.
Publicado 2023

Impact of the COVID-19 Epidemic on a Pan-Asian Academic Oncology Clinical Trial

por Segelov, Eva, Prenen, Hans, Day, Daphne, Macintyre, C. Raina, Foo, Estelle Mei Jye, Ali, Raghib, Wang, Quanyi, Wei, Xiaoting, Lopes, Gilberto de Lima, Ding, Kefeng, Chen, Gong, Chia, John Whay Kuang, Toh, Han Chong
Publicado 2020

Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index

por Day, Daphne, Guo, Christina, Kanjanapan, Yada, Tran, Ben, Spreafico, Anna, Joshua, Anthony M, Wang, Lisa, Abdul Razak, Albiruni R, Leighl, Natasha B, Hansen, Aaron R, Butler, Marcus O, Siu, Lillian L, Desai, Jayesh, Bedard, Philippe L
Publicado 2019

COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers

por Bain, Nathan, Nguyen, Mike, Grech, Lisa, Day, Daphne, McCartney, Amelia, Webber, Kate, Kwok, Alastair, Harris, Sam, Chau, Hieu, Chan, Bryan, Nott, Louise, Hamad, Nada, Tognela, Annette, Underhill, Craig, Loe, Bao Sheng, Freeman, Daniel, Segelov, Eva
Publicado 2022

SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer

por Zhao, Jun, Yu, Xinmin, Huang, Dingzhi, Ma, Zhiyong, Gao, Bo, Cui, Jiuwei, Chu, Qian, Zhou, Qing, Sun, Meili, Day, Daphne, Wu, Jingxun, Pan, Hongming, Wang, Lifeng, Voskoboynik, Mark, Wang, Zhehai, Liu, Yunpeng, Li, Hui, Zhang, Juan, Peng, Yanyan, Wu, Yi-Long
Publicado 2023

A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer

por Day, Daphne, Park, John J., Coward, Jermaine, Markman, Ben, Lemech, Charlotte, Kuo, James C., Prawira, Amy, Brown, Michael P., Bishnoi, Sarwan, Kotasek, Dusan, Strother, R. Matthew, Cosman, Rasha, Su, Rila, Ma, Yiding, Yue, Zenglian, Hu, Hui-han, Wu, Rachel, Li, Peiqi, Tse, Archie N.
Publicado 2023

Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study

por Cohen, Roger B., Delord, Jean-Pierre, Doi, Toshihiko, Piha-Paul, Sarina A., Liu, Stephen V., Gilbert, Jill, Algazi, Alain P., Damian, Silvia, Hong, Ruey-Long, Le Tourneau, Christophe, Day, Daphne, Varga, Andrea, Elez, Elena, Wallmark, John, Saraf, Sanatan, Thanigaimani, Pradeep, Cheng, Jonathan, Keam, Bhumsuk
Publicado 2018

Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia

por Day, Daphne, Grech, Lisa, Nguyen, Mike, Bain, Nathan, Kwok, Alastair, Harris, Sam, Chau, Hieu, Chan, Bryan, Blennerhassett, Richard, Nott, Louise, Hamad, Nada, Tognela, Annette, Hoffman, David, McCartney, Amelia, Webber, Kate, Wong, Jennifer, Underhill, Craig, Sillars, Brett, Winkel, Antony, Savage, Mark, Loe, Bao Sheng, Freeman, Daniel, Segelov, Eva
Publicado 2022

Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in pat...

por Rudin, Charles M, Pandha, Hardev S, Zibelman, Matthew, Akerley, Wallace L, Harrington, Kevin J, Day, Daphne, Hill, Andrew G, O'Day, Steven J, Clay, Timothy D, Wright, Gavin M, Jennens, Ross R, Gerber, David E, Rosenberg, Jonathan E, Ralph, Christy, Campbell, David C, Curti, Brendan D, Merchan, Jaime R, Ren, Yixin, Schmidt, Emmett V, Guttman, Lisa, Gupta, Sumati
Publicado 2023